These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12798827)

  • 1. The heart failure revascularisation trial (HEART): rationale, design and methodology.
    Cleland JG; Freemantle N; Ball SG; Bonser RS; Camici P; Chattopadhyay S; Dutka D; Eastaugh J; Hampton J; Large S; Norell MS; Pennell DJ; Pepper J; Sanda S; Senior R; Smith D
    Eur J Heart Fail; 2003 Jun; 5(3):295-303. PubMed ID: 12798827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
    Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
    Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability.
    Meluzín J; Cerný J; Spinarová L; Toman J; Groch L; Stetka F; Frélich M; Hude P; Krejcí J; Rambousková L; Panovský R
    Eur J Heart Fail; 2003 Jan; 5(1):85-93. PubMed ID: 12559220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Heart Failure Revascularisation Trial (HEART).
    Cleland JG; Calvert M; Freemantle N; Arrow Y; Ball SG; Bonser RS; Chattopadhyay S; Norell MS; Pennell DJ; Senior R
    Eur J Heart Fail; 2011 Feb; 13(2):227-33. PubMed ID: 21156659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimal medical management of ischaemic heart failure?
    Cleland JG; John J; Dhawan J; Clark A
    Br Med Bull; 2001; 59():135-58. PubMed ID: 11756208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and imaging considerations: role of viability.
    Senior R
    Heart Fail Rev; 2006 Jun; 11(2):125-34. PubMed ID: 16937031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study.
    Simonsen JA; Mickley H; Johansen A; Hess S; Thomassen A; Gerke O; Jensen LO; Hallas J; Vach W; Hoilund-Carlsen PF
    BMJ Open; 2017 Aug; 7(8):e016169. PubMed ID: 28801416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of myocardial revascularisation on left ventricular systolic function in patients with and without viable myocardium: should non-viable segments be revascularised?
    Stipac AV; Stankovic I; Vidakovic R; Putnikovic B; Ilic I; Milicic B; Neskovic AN
    Heart; 2013 Dec; 99(23):1749-54. PubMed ID: 23906733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial revascularization for the treatment of post-ischemic heart failure.
    Pagano D; Bonser RS; Camici PG
    Curr Opin Cardiol; 1999 Nov; 14(6):506-9. PubMed ID: 10579068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hibernating heart: reversible left ventricular dysfunction in chronic heart failure.
    Burn S; Walters M; Caplin J
    Postgrad Med J; 1999 Jul; 75(885):419-21. PubMed ID: 10474727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Myocardium in hibernation"--implications for clinical medicine].
    Auer J; Berent R; Eber B
    Wien Med Wochenschr; 2000; 150(6):123-7. PubMed ID: 10893763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of coronary artery disease in heart failure with preserved ejection fraction.
    Hwang SJ; Melenovsky V; Borlaug BA
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2817-27. PubMed ID: 24768876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with advanced multi-vessel coronary artery disease.
    Krecki R; Drozdz J; Krzemińska-Pakuła M
    Kardiol Pol; 2006 Nov; 64(11):1179-85; discussion 1186. PubMed ID: 17165158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary revascularisation in patients with ischaemic cardiomyopathy.
    Ryan M; Morgan H; Petrie MC; Perera D
    Heart; 2021 Apr; 107(8):612-618. PubMed ID: 33436491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete percutaneous revascularisation feasibility in ischaemic heart failure is related to improved outcomes: insights from the COMMIT-HF registry.
    Pyka Ł; Hawranek M; Tajstra M; Gorol J; Lekston A; Gąsior M
    Kardiol Pol; 2017; 75(5):453-461. PubMed ID: 28150287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-photon emission computed tomography for assessment of myocardial viability.
    Schinkel AF; Valkema R; Geleijnse ML; Sijbrands EJ; Poldermans D
    EuroIntervention; 2010 May; 6 Suppl G():G115-22. PubMed ID: 20542817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hibernation and congestive heart failure.
    Dutka DP; Camici PG
    Heart Fail Rev; 2003 Apr; 8(2):167-73. PubMed ID: 12766496
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.